Teduglutide in short bowel syndrome patients: A way back to normal life?

Felix HarpainLukas SchlagerElisabeth HüttererChristopher DawoudSabine KirchnawyJudith StiftPavla KrotkaAnton Stift

Published in: JPEN. Journal of parenteral and enteral nutrition (2021)

Integrating SBS-IF patients treated with teduglutide in a proactive and tight-meshed patient care program significantly improves the clinical outcome, leading to an increased proportion of patients reaching enteral autonomy.

Keyphrases

end stage renal disease
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes